| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218398 Nocathiacin antibiotics |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218381 Fused imidazole derivatives as multidrug resistance modulators |
| 04/17/2001 | US6218380 Pharmaceutical compositions |
| 04/17/2001 | US6218379 As antibacterial |
| 04/17/2001 | US6218377 Methods for the administration of amifostine and related compounds |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6218141 Assembling expression vector using defined nucleotide sequence coding for protein, transforming host cell, then expressing, isolating, and purifying protein |
| 04/17/2001 | US6218136 Methods of the identification of pharmaceutically active compounds |
| 04/17/2001 | US6217904 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant |
| 04/17/2001 | US6217889 Personal care articles |
| 04/17/2001 | US6217884 Isolated, purified polypeptide |
| 04/17/2001 | US6217883 Immunology response |
| 04/17/2001 | US6217882 Inserting heterogeneity nucleotide sequence |
| 04/17/2001 | US6217880 Medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 04/17/2001 | US6217870 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 04/17/2001 | US6217861 pneumococcus; use as drug target for drug screening antibiotics |
| 04/17/2001 | US6217858 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 04/17/2001 | CA2195863C Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby |
| 04/17/2001 | CA2188284C Group a streptococcal polysaccharide immunogenic compositions and methods |
| 04/17/2001 | CA2179396C Tetrahydrofuran antifungals |
| 04/17/2001 | CA2087436C Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 04/17/2001 | CA2072106C Cephalosporin compounds and method for producing them |
| 04/17/2001 | CA2071483C Oligonucleotide analogs with novel linkages |
| 04/17/2001 | CA2010639C Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-thiones |
| 04/13/2001 | CA2321260A1 Oral immunology using plant product containing hepatitis surface antigen |
| 04/13/2001 | CA2320741A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/13/2001 | CA2320518A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025419A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 04/12/2001 | WO2001025275A1 Regulatory/unfolding peptides of ezrin |
| 04/12/2001 | WO2001025274A1 Mitofusins, fzo homologs and functional derivatives thereof |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025257A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025240A1 HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR |
| 04/12/2001 | WO2001025239A2 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025227A2 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
| 04/12/2001 | WO2001025213A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | WO2001025199A1 Urea compounds, process for producing the same and use thereof |
| 04/12/2001 | WO2001025197A1 Antifungal enediynes |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001025187A2 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 04/12/2001 | WO2001024820A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024810A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | WO2001024799A1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 04/12/2001 | WO2001024798A1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 04/12/2001 | WO2001024795A1 RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
| 04/12/2001 | WO2001024792A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | WO2001024791A1 Use of synergistic combinations of a nk1 receptor antagonist and a gaba analog in psychiatric disorders |
| 04/12/2001 | WO2001024787A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | WO2001024785A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024773A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | WO2001024763A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | WO2000066144A3 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections |
| 04/12/2001 | WO2000064915A9 Novel disaccharide antibacterial agents |
| 04/12/2001 | WO2000057907A3 Multivalent dengue virus vaccine |
| 04/12/2001 | WO2000056333A8 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO2000004891A3 Anti-ulcer composition |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388785A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2386841A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | CA2386795A1 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386513A1 Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 04/12/2001 | CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | CA2386387A1 Urea compounds, their production and use |
| 04/12/2001 | CA2386246A1 Altering gene expression with ssdna produced in vivo |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386024A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | CA2385930A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2383836A1 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2348780A1 Regulatory/unfolding peptides of ezrin |
| 04/11/2001 | EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090985A1 Feline-derived T-cells |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |